F13.982 Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced sleep disorder

Name of the Condition

• Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced sleep disorder

Summary

This condition involves the use of sedative, hypnotic, or anxiolytic substances where the pattern of use is not specified, and there is a co-occurring sleep disorder caused by these substances. These drugs are commonly prescribed for anxiety, insomnia, or sedation but may lead to substance-induced sleep disturbances. The unspecified nature indicates insufficient detail to classify the pattern of use further, while the induced sleep disorder represents a complication from substance use.

Causes

The condition arises from the use of sedative, hypnotic, or anxiolytic drugs, such as benzodiazepines or barbiturates. The sleep disorder is a direct result of the substance's effects on the central nervous system, and the unspecified nature indicates insufficient detail to classify the pattern of use beyond the presence of the induced sleep disorder.

Risk Factors

• Prolonged or excessive use of these medications
• History of substance use disorders
• Underlying mental health conditions (e.g., anxiety, depression)
• Easy access to sedative/hypnotic/anxiolytic drugs
• Recreational or non-medical use

Symptoms

• Variable depending on the context of use
• May include cravings, tolerance, or withdrawal symptoms if use is prolonged
• Sleep disturbances directly attributable to the substance use (e.g., insomnia, hypersomnia)
• No specific symptoms are required for this unspecified code

Diagnosis

Diagnosis is based on clinical evaluation of substance use history and assessment of the pattern of use. The unspecified nature indicates that criteria for a more specific disorder (e.g., abuse, dependence) are not met or documented. The presence of a substance-induced sleep disorder must be confirmed through clinical assessment.

Treatment Options

Treatment focuses on addressing the substance use and managing the sleep disorder. This may include discontinuing or tapering the substance, using alternative medications for sleep, and implementing behavioral interventions (e.g., sleep hygiene education). Underlying mental health conditions should also be addressed.

Prognosis and Follow-Up

Prognosis depends on the severity of substance use and the sleep disorder. With appropriate treatment, sleep symptoms may improve, but relapse risk remains if substance use continues. Regular follow-up is important to monitor for recurrence of sleep issues or substance use.

Complications

• Worsening of sleep disorder with continued substance use
• Increased risk of dependence or withdrawal
• Impact on daily functioning due to sleep disturbances
• Potential for other substance-induced disorders

Lifestyle & Prevention

• Avoid non-medical use of sedative/hypnotic/anxiolytic drugs
• Follow prescribed dosing instructions carefully
• Maintain good sleep hygiene practices
• Seek help for underlying mental health conditions
• Limit access to these substances to reduce misuse risk

When to Seek Professional Help

Seek medical attention if sleep disturbances persist or worsen, or if substance use becomes difficult to control. Immediate care is needed for severe withdrawal symptoms or if the sleep disorder impacts safety (e.g., drowsy driving).

Tips for Medical Coders

Use this code when documenting sedative, hypnotic, or anxiolytic use with an unspecified pattern and a co-occurring sleep disorder induced by these substances. Ensure clinical documentation supports the presence of the sleep disorder and the unspecified nature of the substance use. Do not use this code if a more specific pattern of use (e.g., abuse, dependence) is documented.